Testing for BRCA mutations linked to breast and ovarian cancers could become easier and more accessible with the help of artificial intelligence, potentially allowing earlier treatment.

Screening for pancreatic cancer is recommended for individuals with the above risk factors around 50 years of age or 10 years ...

Pancreatic cancer, a highly aggressive disease, often diagnosed late, has a low survival rate. Genetic testing provides ...

7 14–16 Cumulative ovarian cancer risk to age 80 was estimated to be 44% for BRCA1 mutation carriers and 17% for BRCA2 mutations carriers in a study using data from a prospective cohort.1 This ...

Oncology nurses “play a pivotal role in guiding patients” through the genetic testing process, an expert explained.

Alternatively, the same BRCA deficiency that prompted genomic ... and these three studies provide a compelling rationale for testing combinations of cisplatin with agents that target pathways ...

For example, Tengs and Berry 60 calculated that BRCA testing of the general US population would be regarded as not cost-effective at $1.6 million per QALY. They calculated that testing of women at ...

It was a mother’s instinct and fierce determination that helped to save the sight of Melbourne schoolboy Krisshiv.

Quest Partners LLC lifted its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 50.8% during the third quarter, according to the company in its most recent Form 13F filing with the ...

Life has a way of testing couples at every stage of their lives — just ask John Mulaney and Olivia Munn. From meeting a ...

Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP ...